3 unknown. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
| Phase 3 | 1 | Unknown 1 |
Follow SBRT: new trials by email Literature Review of SBRT trials Research Report on SBRT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiation Therapy Pre-therapeutic imaging test - SBRT, Non-small Cell Lung Cancer | Phase 2 / Phase 3 | Unknown | University Hospital, Brest | 60 | 2021-07-15 | 2022-09-19 |
| Combination of Sintilimab and Stereotactic Body Radiotherapy in Advanced Metastatic HCC Stereotactic body radiation therapy, Anti-PD-1 antibody drug named Sintilimab - Stage IV HCC, Immunotherapy | Phase 2 | Unknown | West China Hospital | 84 | 2020-07-01 | 2020-09-14 |
| SBRT in Multi-metastatic NSCLC Patients Which Are Pan-negative for Driver Mutations SBRT concurrent with GM-CSF, two-drug chemotherapy containing platinum, including carboplatin/Cisplatin + pemetrexed/docetaxel/paclitaxel/etoposide/gemcitabine/vinorelbine/albumin-bound paclitaxel - NSCLC, SBRT | Phase 2 | Unknown | Shanghai Chest Hospital | 50 | 2016-11-01 | 2016-12-01 |
Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1)
Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Lung Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
Cisplatin (1) · Granulocyte-Macrophage Colony-Stimulating Factor (1) · Radiosurgery (1)
Shanghai Chest Hospital (1) · University Hospital, Brest (1) · West China Hospital (1)
China (2) · France (1)
PMID 22560555, PMID 26095785, PMID 26484629, PMID 26582738, PMID 26951040, PMID 40591115